Skip to main content
Log in

Protective effect of triflusal and its main metabolite HTB in an in vitro model of anoxia-reoxygenation in rat brain slices: comparison with acetylsalicylic and salicylic acids

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Triflusal is a fluorinated derivative of acetylsalicylic acid (ASA) with demonstrated antithrombotic activity. Recently, evidence for a neuroprotective effect has been obtained. The aim of this study was to compare the neuroprotective effects of the main metabolite of triflusal (2-hydroxy-4-trifluoromethylbenzoic acid, HTB) and the ASA metabolite salicylic acid (SA) in an in vitro model of anoxia-reoxygenation in rat brain slices. Rat brain slices (n=10 per group) were subjected to a period of anoxia followed by 180 min reoxygenation. We measured oxidative stress parameters (lipid peroxidation, glutathione system), prostaglandins (PGE2), nitric oxide pathway activity (NO) (nitrites+nitrates, constitutive and inducible NO synthase activity) and LDH efflux, a biochemical marker of cell death. Various concentrations (10, 100 and 1,000 μM) of triflusal, HTB, ASA or SA were tested. Triflusal at 10, 100 and 1,000 μM decreased LDH efflux in rat brain slices after anoxia/reoxygenation by 24%, 35% and 49% respectively. This effect was proportionately greater than that of ASA (0%, 13% and 32%). The results with HTB were similar to those with triflusal, whereas SA showed a greater protective effect than ASA (13%, 33% and 35%). The antioxidant effects of HTB and SA on the biochemical mechanisms of cell damage studied here were also greater than the effects of triflusal and ASA, a finding attributable mainly to the decrease in lipid peroxidation and to the ability of HTB to also increase glutathione levels. The triflusal metabolite reduced inducible NO synthase activity by 18%, 21% and 30%, whereas SA inhibited this activity by 9%, 17% and 23%. Triflusal and HTB led to greater increases in NO synthase than ASA or AS. In conclusion, the metabolite HTB plays an important role in the neuroprotective effect of triflusal, at least in the experimental model of anoxia-reoxygenation tested here.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Acarin L, González B, Castellano B (2002) Decrease of proinflammatory molecules correlates with neuroprotective effect of the fluorinated salicylate triflusal after postnatal excitotoxic damage. Stroke 33:2499–2505

    Article  CAS  PubMed  Google Scholar 

  • Acarin L, González B, Castellano B (2000) Oral administration of the anti-inflammatory substance triflusal results in the downregulation of constitutive transcription factor NF-κB in the postnatal rat brain. Neurosci Lett 288:41–44

    Article  CAS  PubMed  Google Scholar 

  • Acarin L, González B, Castellano B (2001) Triflusal posttreatment inhibits glial nuclear factor-κB, downregulates the glial response, and is neuroprotective in an excitotoxic injury model in postnatal brain. Stroke 32:2394–2402

    CAS  PubMed  Google Scholar 

  • Antithrombotic Trialists’ Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 324:71–86

    Google Scholar 

  • Bosmann HB, Hemsworth BA (1970) Intraneural mitochondria. J Biol Chem 245:363–371

    CAS  PubMed  Google Scholar 

  • Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254

    Article  CAS  PubMed  Google Scholar 

  • De La Cruz JP, Pavía J, García-Arnés J, Sánchez de la Cuesta F (1987) Effects of triflusal and aspirin on platelet aggregation in whole blood and platelet-rich plasma of diabetic patients. Eur J Haematol 40:232–236

    Google Scholar 

  • De La Cruz JP, Carrasco T, Ortega G, Sánchez de la Cuesta F (1992a) Inhibition of ferrous-induced lipid peroxidation by pyrimido-pyrimidine derivatives in human liver membranes. Lipids 27:192–194

    PubMed  Google Scholar 

  • De La Cruz JP, Mata JM, Sánchez de la Cuesta F (1992b) Triflusal vs aspirin on the inhibition of human platelet and vascular cyclooxygenase. Gen Pharmacol 23:297–300

    PubMed  Google Scholar 

  • De La Cruz JP, Blanco E, Sánchez de la Cuesta F (2000) Effect of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway. Eur J Pharmacol 397:35–41

    Google Scholar 

  • De La Cruz JP, Guerrero A, Paniego MJ, Arranz I, Moreno A, Sánchez de la Cuesta F (2002) Effect of aspirin on prostanoids and nitric oxide production in streptozotocin-diabetic rats with ischemic retinopathy. Naunyn-Schmiedebergs Arch Pharmacol 365:96–101

    Google Scholar 

  • De La Cruz JP, Guerrero A, González-Correa JA, Arrebola MM, Sánchez de la Cuesta F (2004) Antioxidant effect of acetylsalicylic acid in rat brain slices subjected to hypoxia. J Neurosci Res 75:280–290

    Article  PubMed  Google Scholar 

  • Flohé L, Gunzler WA (1985) Assays of glutathione peroxidase. Methods Enzymol 105:114–121

    Google Scholar 

  • Gálvez J, De la Cruz JP, Zarzuelo A, Sánchez-Medina F, Jiménez J, Sánchez de la Cuesta F (1994) Oral administration of quercitrin modifies intestinal oxidative status in rats. Gen Pharmacol 25:1237–1243

    Google Scholar 

  • González-Correa JA, Arrebola MM, Ureña I, Guerrero A, Muñoz-Marin J, Ruiz-Villafranca D, Sánchez de la Cuesta F, De La Cruz JP (2004) Effects of triflusal in rat brain oxidative stress, prostaglandin production and nitric oxide pathway in a model of reoxygenation after oxygen-glucose deprivation. Brain Res 1011:148–155

    Article  CAS  PubMed  Google Scholar 

  • Grilli M, Pizzi M, Memo M, Spano P (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappa B activation. Science 274:1383–1385

    Article  CAS  PubMed  Google Scholar 

  • Guerrero A, González-Correa JA, Arrebola MM, Muñoz-Marín J, Sánchez de la Cuesta F, De La Cruz JP (2004) Antioxidant effects of a single dose of acetylsalicylic acid and salicylic acid in rat brain slices subjected to oxygen-glucose deprivation in relation with its antiplatelet effect. Neurosci Lett 358:153–156

    Article  CAS  PubMed  Google Scholar 

  • Hissin PJ, Hill R (1976) A fluorimetric method of determination of oxidized and reduced glutathione in tissues. Anal Biochem 74:214–226

    CAS  PubMed  Google Scholar 

  • Kim SJ, Kim YK, Takagi G, Huang CH, Geng YJ, Vatner SF (2002) Enhanced iNOS function in myocytes one day after brief ischemic episode. Am J Physiol 282:H423–H428

    Google Scholar 

  • Kontos HA (2001) Oxygen radicals in cerebral ischemia: the 2001 Willis Lecture. Stroke 32:2712–2716

    CAS  PubMed  Google Scholar 

  • Lobner D (2000) Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis?. J Neurosci Methods 96:147–152

    Article  CAS  PubMed  Google Scholar 

  • Lopez-Farré A, Caramelo C, Esteban A, Alberola ML, Millas I, Monton M, Casado S (1995) Effect of aspirin on platelet-neutrophil interaction. Role of nitric oxide and endothelin-1. Circulation 91:2080–2088

    PubMed  Google Scholar 

  • Matias-Guiu J, Ferro JM, Alvarez-Sabin J, Tores F, Jiménez MD, Lago A, Melo T, TACIP Investigators (2003) Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP study: a randomised, double-blind, multicenter trial. Stroke 34:840–848

    Article  CAS  PubMed  Google Scholar 

  • Moro MA, De Alba J, Leza JC, Lorenzo P, Fernández AP, Ventura ML, Boscá L, Rodrigo J, Lizasoain I (1998) Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. Eur J Neurosci 10:445–456

    Article  CAS  PubMed  Google Scholar 

  • Moro MA, De Alba J, Cárdenas A, De Cristóbal J, Leza JC, Lizasoain I, Díaz-Guerra MJM, Boscá L, Lorenzo P (2000) Mechanisms of the neuroprotective effect of aspirin after oxygen and glucose deprivation in rat forebrain slices. Neuropharmacology 39:1309–1318

    Article  CAS  PubMed  Google Scholar 

  • Murdoch J, Hall R (1990) Brain protection: physiological and pharmacological considerations: part I. The physiology of brain injury. Can J Anaesth 37:663–671

    CAS  PubMed  Google Scholar 

  • Sánchez de Miguel L, Casado S, Farré J, García-Durán M, Rico LA, Montón M, Romero J, Bellver T, Sierra MP, Guerra JI, Mata P, Esteban A, López-Farré A (1998) Comparison of in vitro effects of triflusal and acetylsalicylic acid on nitric oxide synthesis by human neutrophils. Eur J Pharmacol 343:547–565

    Google Scholar 

  • Sánchez de Miguel L, Jiménez A, Montón M, Farré J, Arriero MM, Rodríguez-Feo JA, García-Cañete J, Rico L, Gómez J, Núñez A, Casado S, López-Farré A (2000) A 4-trifluoromethyl derivative of salicylate, triflusal, stimulates nitric oxide production by human neutrophils: role in platelet function. Eur J Clin Invest 30:811–817

    Google Scholar 

  • Warholm M, Guthenberg C, von Bahr C, Mannervik B (1985) Glutathione transferases from human liver. Meth Enzymol 113:449–503

    Google Scholar 

Download references

Acknowledgements

This work was supported by LOU (Ley Orgánica de Universidades) project 8.06/79.1794 from Uriach & Cia. We thank A. Pino Blanes for his excellent technical assistance, and K. Shashok for improving the use of English in the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. P. De La Cruz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

González-Correa, J.A., Arrebola, M.M., Ureña, I.M. et al. Protective effect of triflusal and its main metabolite HTB in an in vitro model of anoxia-reoxygenation in rat brain slices: comparison with acetylsalicylic and salicylic acids. Naunyn-Schmiedeberg's Arch Pharmacol 371, 81–88 (2005). https://doi.org/10.1007/s00210-004-1001-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-004-1001-y

Keywords

Navigation